ResearcherWenzhou Medical UniversityActive in the last 2 years

Bo Peng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2608-3134; OpenAlex author ID A5002475687. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

A FAP-α-activatable near-infrared theranostic probe for fluorescence imaging of pancreatic cancer and potent in vitro photodynamic activity. Last author DOI 10.1016/j.bioorg.2025.109326 ↗
NQO-1 Enzyme-Activated NIR Theranostic Agent for Pancreatic Cancer. Co-author DOI 10.1021/acs.analchem.2c01189 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jiao Xu · 1 shared paper, 2026 · strength 0.39
- Paper A FAP-α-activatable near-infrared theranostic probe for fluorescence imaging of pancreatic cancer and potent in vitro p… DOI 10.1016/j.bioorg.2025.109326 ↗
Zhipeng Li · 1 shared paper, 2026 · strength 0.39
- Paper A FAP-α-activatable near-infrared theranostic probe for fluorescence imaging of pancreatic cancer and potent in vitro p… DOI 10.1016/j.bioorg.2025.109326 ↗
Gang Chen · 1 shared paper, 2022 · strength 0.17
- Paper NQO-1 Enzyme-Activated NIR Theranostic Agent for Pancreatic Cancer. DOI 10.1021/acs.analchem.2c01189 ↗
Zhipeng Li · 1 shared paper, 2022 · strength 0.17
- Paper NQO-1 Enzyme-Activated NIR Theranostic Agent for Pancreatic Cancer. DOI 10.1021/acs.analchem.2c01189 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.